Preventing Respiratory Syncytial Virus in Children in France: A Narrative Review of the Importance of a Reinforced Partnership Between Parents, Healthcare Professionals, and Public Health Authorities.
Children
France
Immunisation
Infants
Nirsevimab
Palivizumab
Pharmacoeconomics
Primary healthcare
Public health
Respiratory syncytial virus
Journal
Infectious diseases and therapy
ISSN: 2193-8229
Titre abrégé: Infect Dis Ther
Pays: New Zealand
ID NLM: 101634499
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
17
10
2022
accepted:
21
11
2022
pubmed:
16
12
2022
medline:
16
12
2022
entrez:
15
12
2022
Statut:
ppublish
Résumé
The highly contagious respiratory syncytial virus (RSV) is responsible for up to approximately 50,000 hospitalisations during each RSV season in children aged under 5 years in France, with the burden greatest in infants younger than 1 year who were born at term. There is a need for a strategy to universally protect young children from RSV infection, and thereby reduce the pressure that RSV places every year on RSV-infected children, their parents, and French healthcare systems. Potential strategies currently undergoing clinical investigation include passive immunisation via maternal vaccination or administration of long-acting monoclonal antibodies at or soon after birth, followed by vaccination later in infancy or childhood. An ongoing partnership and collaboration between parents, public health authorities, and frontline primary healthcare will need to be reinforced once these new RSV prevention strategies are available, to facilitate their use and ensure that all children receive adequate protection from the start of their first RSV season.
Identifiants
pubmed: 36520324
doi: 10.1007/s40121-022-00737-2
pii: 10.1007/s40121-022-00737-2
pmc: PMC9753881
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
317-332Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. The Author(s).
Références
Arch Public Health. 2017 Mar 3;75:13
pubmed: 28270912
Eur Respir J. 2021 Oct 1;58(3):
pubmed: 33888523
Curr Top Microbiol Immunol. 2013;372:39-57
pubmed: 24362683
Front Immunol. 2019 May 07;10:1006
pubmed: 31134078
Euro Surveill. 2021 Jul;26(29):
pubmed: 34296674
Annu Rev Immunol. 2017 Apr 26;35:501-532
pubmed: 28226227
Am J Respir Crit Care Med. 2021 Mar 1;203(5):594-603
pubmed: 32871092
Euro Surveill. 2021 Jul;26(29):
pubmed: 34296673
Am Fam Physician. 2017 Jan 15;95(2):94-99
pubmed: 28084708
Clin Infect Dis. 2020 Jun 24;71(1):211-214
pubmed: 31630167
Int J Mol Sci. 2021 Apr 02;22(7):
pubmed: 33918185
Euro Surveill. 2021 Jul;26(29):
pubmed: 34296672
J Med Virol. 2021 Jul;93(7):4099-4101
pubmed: 33760278
Euro Surveill. 2018 Feb;23(5):
pubmed: 29409569
Epidemiol Infect. 2014 Jul;142(7):1362-74
pubmed: 24029023
N Engl J Med. 2022 Mar 3;386(9):892-894
pubmed: 35235733
BMC Infect Dis. 2021 Aug 2;21(1):730
pubmed: 34340679
Pediatrics. 2013 Aug;132(2):e341-8
pubmed: 23878043
Acta Paediatr. 2021 Apr;110(4):1297-1299
pubmed: 33506533
Arch Pediatr. 2018 Feb;25(2):89-94
pubmed: 29395887
Value Health. 2003 Mar-Apr;6(2):100-6
pubmed: 12641860
Policy Polit Nurs Pract. 2021 Feb;22(1):41-50
pubmed: 33050785
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30547-30553
pubmed: 33168723
Lancet Respir Med. 2021 Feb;9(2):175-185
pubmed: 32971018
Cochrane Database Syst Rev. 2021 Nov 16;11:CD013757
pubmed: 34783356
Vaccine. 2020 Jul 22;38(34):5474-5479
pubmed: 32600912
N Engl J Med. 2020 Jul 30;383(5):487-488
pubmed: 32726536
Infect Dis Now. 2021 Aug;51(5):418-423
pubmed: 33991720
J Glob Health. 2017 Jun;7(1):010412
pubmed: 28702175
N Engl J Med. 2022 Mar 3;386(9):837-846
pubmed: 35235726
Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2389-2395
pubmed: 34347190
J Infect Dis. 2022 Aug 12;226(Suppl 1):S110-S116
pubmed: 35333332
Curr Top Microbiol Immunol. 2013;372:3-38
pubmed: 24362682
Arch Pediatr. 2009 Nov;16(11):1443-52
pubmed: 19767182
Am J Respir Crit Care Med. 2021 Mar 1;203(5):538-539
pubmed: 32986467
J Infect Dis. 2020 Oct 7;222(Suppl 7):S680-S687
pubmed: 32227101
N Engl J Med. 2020 Jul 30;383(5):415-425
pubmed: 32726528
N Engl J Med. 2016 Jan 7;374(1):62-72
pubmed: 26735994
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Emerg Themes Epidemiol. 2021 Oct 21;18(1):15
pubmed: 34674730
Front Pediatr. 2021 Dec 10;9:764583
pubmed: 34956977
Vaccine. 2018 Oct 29;36(45):6591-6593
pubmed: 30266485
J Infect Dis. 2017 Jan 1;215(1):1-3
pubmed: 27738053
Pediatr Infect Dis J. 2021 Dec 1;40(12):e511-e514
pubmed: 34260480
J Infect Dis. 2020 Mar 28;221(8):1256-1270
pubmed: 31165865
N Engl J Med. 2020 Jul 30;383(5):426-439
pubmed: 32726529
Euro Surveill. 2019 Oct;24(40):
pubmed: 31595876
Arch Dis Child. 2004 Jun;89(6):562-7
pubmed: 15155404
Vaccine. 2020 Jan 10;38(2):251-257
pubmed: 31740097
Influenza Other Respir Viruses. 2022 Jul;16(4):717-725
pubmed: 35014194
Arch Fr Pediatr. 1990 Dec;47(10):725-9
pubmed: 2082846
Clin Infect Dis. 2021 Jan 27;72(2):319-322
pubmed: 33501967
Vaccine. 2020 Mar 4;38(11):2435-2448
pubmed: 31974017
Nat Rev Immunol. 2021 Feb;21(2):83-100
pubmed: 33353987
Children (Basel). 2021 Dec 06;8(12):
pubmed: 34943339
Infect Dis Ther. 2022 Feb;11(1):277-292
pubmed: 34813073
Hum Vaccin Immunother. 2018 Jan 2;14(1):234-244
pubmed: 29194014
JAMA Pediatr. 2022 Mar 01;176(3):270-279
pubmed: 34928313
Lancet Respir Med. 2023 Apr;11(4):341-353
pubmed: 36372082
Intensive Care Med. 2014 Jan;40(1):84-91
pubmed: 24158409
Infect Dis Ther. 2021 Mar;10(Suppl 1):47-60
pubmed: 33656652
Ther Adv Infect Dis. 2019 Jul 29;6:2049936119865798
pubmed: 31384456
J Hosp Med. 2020 Jun;15(6):325-330
pubmed: 32490796
Pediatrics. 1998 Sep;102(3 Pt 1):531-7
pubmed: 9738173
Ital J Pediatr. 2021 Oct 2;47(1):198
pubmed: 34600591
Infect Dis Ther. 2018 Mar;7(1):87-120
pubmed: 29470837
Pediatrics. 2021 Apr;147(4):
pubmed: 33731367
J Infect Dis. 2018 Apr 11;217(9):1356-1364
pubmed: 29390105
Pediatr Pulmonol. 2021 Dec;56(12):3669-3673
pubmed: 34473914
J Infect Dis. 2019 Oct 22;220(11):1802-1815
pubmed: 31402384
Presse Med. 1988 Sep 24;17(32):1633-6
pubmed: 2973014
N Engl J Med. 2009 Feb 5;360(6):588-98
pubmed: 19196675
Infect Dis Ther. 2016 Sep;5(3):271-98
pubmed: 27480325